TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Primary Health Care
KW - Safety-net Providers
KW - buprenorphine
KW - Nurse care managers
KW - opioid use disorder
KW - primary care
AU - N. Beharie
AU - M. Kaplan-Dobbs
AU - A. Urmanche
AU - D. Paone
AU - A. Harocopos
A1 - 
AB - BACKGROUND AND OBJECTIVE: To promote increased access to and retention in buprenorphine treatment for opioid use disorder, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) implemented the Buprenorphine Nurse Care Manager Initiative (BNCMI) in 2016, in which nurse care managers (NCMs) coordinate buprenorphine treatment in safety-net primary care clinics. To explore how patients experienced the care they received from NCMs, DOHMH staff conducted in-person, in-depth interviews with patients who had, or were currently receiving, buprenorphine treatment at BNCMI clinics. Participants were patients who were receiving, or had received, buprenorphine treatment through BNCMI at one of the participating safety-net primary care practices. METHODS: The study team used a thematic analytic and framework analysis approach to capture concepts related to patient experiences of care received from NCMs, and to explore differences between those who were in treatment for at least six consecutive months and those who left treatment within the first six months. RESULTS: Themes common to both groups were that NCMs showed care and concern for patients' overall well-being in a nonjudgmental manner. In addition, NCMs provided critical clinical and logistical support. Among out-of-treatment participants, interactions with the NCM were rarely the catalyst for disengaging with treatment. Moreover, in-treatment participants perceived the NCM as part of a larger clinical team that collectively offered support, and the care provided by NCMs was often a motivating factor for them to remain engaged in treatment. CONCLUSION: Findings suggest that by providing emotional, clinical, and logistical support, as well as intensive engagement (e.g., frequent phone calls), the care that NCMs provide could encourage retention of patients in buprenorphine treatment.
AD - New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY 11101, USA. Electronic address: nbeharie@health.nyc.gov.; New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY 11101, USA. Electronic address: mkaplan5@health.nyc.gov.; New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY 11101, USA. Electronic address: aurmanche@health.nyc.gov.; New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY 11101, USA. Electronic address: dpaone@health.nyc.gov.; New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY 11101, USA. Electronic address: aharocopos@health.nyc.gov.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Opioids & Substance Use
CY - United States
DO - 10.1016/j.jsat.2021.108633
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
N2 - BACKGROUND AND OBJECTIVE: To promote increased access to and retention in buprenorphine treatment for opioid use disorder, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) implemented the Buprenorphine Nurse Care Manager Initiative (BNCMI) in 2016, in which nurse care managers (NCMs) coordinate buprenorphine treatment in safety-net primary care clinics. To explore how patients experienced the care they received from NCMs, DOHMH staff conducted in-person, in-depth interviews with patients who had, or were currently receiving, buprenorphine treatment at BNCMI clinics. Participants were patients who were receiving, or had received, buprenorphine treatment through BNCMI at one of the participating safety-net primary care practices. METHODS: The study team used a thematic analytic and framework analysis approach to capture concepts related to patient experiences of care received from NCMs, and to explore differences between those who were in treatment for at least six consecutive months and those who left treatment within the first six months. RESULTS: Themes common to both groups were that NCMs showed care and concern for patients' overall well-being in a nonjudgmental manner. In addition, NCMs provided critical clinical and logistical support. Among out-of-treatment participants, interactions with the NCM were rarely the catalyst for disengaging with treatment. Moreover, in-treatment participants perceived the NCM as part of a larger clinical team that collectively offered support, and the care provided by NCMs was often a motivating factor for them to remain engaged in treatment. CONCLUSION: Findings suggest that by providing emotional, clinical, and logistical support, as well as intensive engagement (e.g., frequent phone calls), the care that NCMs provide could encourage retention of patients in buprenorphine treatment.
PP - United States
PY - 2022
SN - 1873-6483; 0740-5472
SP - 108633
T1 - "I didn't feel like a number": The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings
T2 - Journal of substance abuse treatment
TI - "I didn't feel like a number": The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings
U1 - Education & Workforce; Opioids & Substance Use
U2 - 34688496
U3 - 10.1016/j.jsat.2021.108633
VL - 132
VO - 1873-6483; 0740-5472
Y1 - 2022
Y2 - Jan
ER -